Attention deficit hyperactivity disorder

An in-depth report on the causes, diagnosis, treatment, and prevention of ADHD.

I Would Like to Learn About:

Related Reports

Restless legs synd...

References

American Academy of Child & Adolescent Psychiatry and American Psychiatric Association website. ADHD parents medication guide. www.aacap.org/App_Themes/AACAP/Docs/resource_centers/adhd/adhd_parents_medication_guide_201305.pdf. Updated July 2013. Accessed August 5, 2020.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Arlington, VA: American Psychiatric Association; 2013.

Franz AP, Bolat GU, Bolat H, et al. Attention-deficit/hyperactivity disorder and very preterm/very low birth weight: a meta-analysis. Pediatrics. 2018;141(1). PMID: 29255083 pubmed.ncbi.nlm.nih.gov/29255083/.

Goode AP, Coeytaux RR, Maslow GR, et al. Nonpharmacologic treatments for attention-deficit/hyperactivity disorder: a systematic review. Pediatrics. 2018;141(6). PMID: 29848556 pubmed.ncbi.nlm.nih.gov/29848556/.

Heilskov Rytter MJ, Andersen LB, Houmann T, et al. Diet in the treatment of ADHD in children - a systematic review of the literature. Nord J Psychiatry. 2015;69(1):1-18. PMID: 24934907 pubmed.ncbi.nlm.nih.gov/24934907/.

Hennissen L, Bakker MJ1 Banaschewski T, et al. Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine. CNS Drugs. 2017;31(3):199-215. PMID: 28236285 pubmed.ncbi.nlm.nih.gov/28236285/.

Huang L, Wang Y, Zhang L, et al. Maternal smoking and attention-deficit/hyperactivity disorder in offspring: a meta-analysis. Pediatrics. 2018;141(1). PMID: 29288161 pubmed.ncbi.nlm.nih.gov/29288161/.

Kemper AR, Maslow GR, Hill S, et al. Attention deficit hyperactivity disorder: diagnosis and treatment in children and adolescents [internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); AHRQ Comparative Effectiveness Reviews. 2018 Jan. Report No: 18-EHC005-EF. PMID: 29558081 pubmed.ncbi.nlm.nih.gov/29558081/.

Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019;56:14-34. PMID: 30453134 pubmed.ncbi.nlm.nih.gov/30453134/.

Leung AK, Hon KL. Attention-deficit/hyperactivity disorder. Adv Pediatr. 2016;63(1):255-280. PMID: 27426904 pubmed.ncbi.nlm.nih.gov/27426904/.

Lopez PL, Torrente FM, Ciapponi A, et al. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2018;3:CD010840. PMID: 29566425 pubmed.ncbi.nlm.nih.gov/29566425/.

Naguy A. Psychopharmacotherapy of attention deficit-hyperactivity disorder in children with comorbid conditions. Pediatr Neurol. 2018;82:7-12. PMID: 29678368 pubmed.ncbi.nlm.nih.gov/29678368/.

Prince JB, Wilens TE, Spencer TJ, Biederman J. Pharmacotherapy of attention-deficit/hyperactivity disorder across the lifespan. In: Stern TA, Fava M, Wilens TE, Rosenbaum JF, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2nd ed. Philadelphia, PA: Elsevier; 2016:chap 49.

Punja S, Shamseer L, Hartling L, et al. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev. 2016;2:CD009996. PMID: 26844979 pubmed.ncbi.nlm.nih.gov/26844979/.

Ruiz-Goikoetxea M, Cortese S, Aznarez-Sanado M, et al. Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2018;84:63-71. PMID: 29162520 pubmed.ncbi.nlm.nih.gov/29162520/.

Storebø OJ, Pedersen N, Ramstad E, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018;5:CD012069. PMID: 29744873 pubmed.ncbi.nlm.nih.gov/29744873/.

Stickley A, Koyanagi A, Takahashi H, Ruchkin V, Inoue Y, Kamio Y. Attention-deficit/hyperactivity disorder and physical multimorbidity: A population-based study. Eur Psychiatry. 2017;45:227-234. PMID: 28957792 pubmed.ncbi.nlm.nih.gov/28957792/.

Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016;387(10024):1240-1250. PMID: 26386541 pubmed.ncbi.nlm.nih.gov/26386541/.

Urion DK. Attention-deficit/hyperactivity disorder. In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF, eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016:chap 33.

Volkow ND, Swanson JM. Clinical practice: Adult attention deficit-hyperactivity disorder. N Engl J Med. 2013;369(20):1935-1944. PMID: 24224626 pubmed.ncbi.nlm.nih.gov/24224626/.

Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents [published correction appears in Pediatrics. 2020 Mar;145(3):]. Pediatrics. 2019;144(4):e20192528. PMID: 31570648 pubmed.ncbi.nlm.nih.gov/31570648/.

BACK TO TOP

Review Date: 11/7/2020  

Reviewed By: Fred K. Berger, MD, addiction and forensic psychiatrist, Scripps Memorial Hospital, La Jolla, CA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2022 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.